Measles is back, and New York has declared a health emergency while Pennsylvania has recorded more than a thousand cases and five deaths. Meanwhile, a researcher at a Russian plague laboratory has died of unexplained pneumonia, Florida is experiencing one of the largest dengue outbreaks in decades, and a new federal regulation may make prescription medications from Canada more expensive.
But there is some encouraging news. A new obesity drug, petrelintide, targets a different hormone pathway and may offer another option for patients who struggle with GLP-1 side effects.
This week on Dr. Simpson Unfiltered, we look at the science behind these headlines, what we know, what we don’t, and why it matters.
